GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
202
c/glp1canada·posted 2 years ago by u/zaid_grimaldi

three years of special authorization threads, summarised so you do not have to read them

Discussion

three years of special authorization threads, summarised so you do not have to read them — a position I have arrived at slowly and would like tested.

The pharmacist sorted in five minutes what the phone line had not managed in a fortnight.

Kept every form and reference number. When they had no record of a submission, I did.

Criteria changed at plan renewal and the denial that had been immovable simply did not apply any more.

Happy to answer the boring questions. Those are usually the ones worth asking.

209 up / 7 down97% upvoted19 commentsid fimjol23 May 2024

19 comments

15 in this archive, depth 3

best — the order this archive was captured in

u/rania_diallo25 points·2 years ago

Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing.

replysharereportpermalink
u/controversial_only12 points·2 years ago

quantity limits are as common a barrier as coverage itself

replysharereportpermalink
u/the_poster_in_question_20269 points·2 years ago

a denial letter names a criterion, that is your handle

replysharereportpermalink
load more comments (3) →
u/anya_rautio0 points·2 years ago

Disagree — that is your province’s formulary position and it does not carry to another.

replysharereportpermalink
u/diego_almeida1 point·2 years ago

Correction: that is regulatory approval, not coverage. They are separate decisions by separate bodies.

replysharereportpermalink
u/teodor_jansen10 points·2 years ago

Provincial plan, employer plan, or paying cash?

replysharereportpermalink
u/the_poster_in_question_20266 points·2 years ago

How to write a special authorization request that gets approved.

Get the published criteria for your province. Answer them explicitly, in their own terms, in the same order. Attach what has been documented — what was tried, at what dose, for how long, with what outcome — as dates rather than narrative. Where a criterion cannot be met, have the prescriber say why in the criterion’s own language rather than around it.

Members here who have done this describe a much better hit rate than those who submitted a clinical letter that did not engage with the form. It is an administrative exercise, and treating it as one is the whole trick. None of which is advice — it is what the threads report.

replysharereportpermalink
u/adaeze_batista0 points·2 years ago

Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary. Which one applies determines everything about the route.

replysharereportpermalink
u/ffmi_watcher6 points·2 years ago

Cosigning on quantity limits. They stop as many people as outright denials do and get discussed far less.

replysharereportpermalink
u/zeynep_ndiaye3 points·2 years ago

the exception drug status route exists in several provinces

replysharereportpermalink
u/hedda_aguirre2 points·2 years ago

I would not read one pharmacy’s cash price as the going rate. The spread is real.

replysharereportpermalink
u/sequence_checkerresearch peptides2 points·2 years ago

Quantity limits restrict how much may be dispensed in a period even where coverage exists. They are a distinct barrier and require a distinct request.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.